(Q31016981)

28 June 2017

title

Data monitoring in randomized controlled trials: surveys of recent practice and policies (English)

1 reference

28 June 2017

0 references

2

Diana Elbourne

1 reference

28 June 2017

Felicity Clemens

1

1 reference

28 June 2017

Janet Darbyshire

series ordinal

3

1 reference

28 June 2017

Stuart Pocock

series ordinal

4

1 reference

28 June 2017

DAMOCLES Group

series ordinal

5

1 reference

28 June 2017

publication date

1 January 2005

1 reference

28 June 2017

1 reference

28 June 2017

volume

2

1 reference

28 June 2017

issue

1

1 reference

28 June 2017

page(s)

22-33

1 reference

Data monitoring committees for multicenter clinical trials sponsored by the National Institutes of Health. I. Roles and membership of data monitoring committees for trials sponsored by the National Eye Institute

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN064OA

Practical issues in data monitoring of clinical trials: summary of responses to a questionnaire at NIH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN064OA

A survey of monitoring practices in cancer clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN064OA

Systematic qualitative review of the literature on data monitoring committees for randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN064OA

Small group processes relevant to data monitoring committees in controlled clinical trials: an overview of reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN064OA

Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN064OA

Treatment effects monitoring committees and early stopping in large clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN064OA

Should statisticians reporting to data monitoring committees be independent of the trial sponsor and leadership?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN064OA

The independent statistician for data monitoring committees

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN064OA

Conflicts of interest in data monitoring of industry versus publicly financed clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN064OA

Independence of the statistician who analyses unblinded data

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN064OA

A major trial needs three statisticians: why, how and who?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN064OA

Operational and policy considerations of data monitoring in clinical trials: the Diabetes Control and Complications Trial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN064OA

10.1191/1740774505CN064OA

21 January 2018

Identifiers

DOI

1 reference

28 June 2017

1 reference